WE ENGINEER THE
PHAGE TAILS
To develop a cocktail of phages that target the diversity of E. Coli human microbiome strains
The TBX™ technology platform converges computational, synthetic, and experimental biological tools, to engineer phages as oral medicines that deliver CRISPR payloads and reprogram selected bacteria with exceptional precision, resulting in a robust and durable therapeutic effect during the treatment period.
WE ENGINEER THE
To develop a cocktail of phages that target the diversity of E. Coli human microbiome strains
WE ENGINEER THE
To deliver uniquely designed TBX™ DNA Cargo to control specific microbiome activities
OUR TBX™ DNA CARGOS CONTAIN A CRISPR-CAS3 PROTECTION SYSTEM ENABLING TARGET BACTERIA TO SURVIVE A LYTIC PHAGE ATTACK
